Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial
Authors
MICHAEL SZAREK
Warren H. Capell (ORCID: https://orcid.org/0000-0002-1073-3721)
J. Ycas (ORCID: https://orcid.org/0000-0001-7783-1273)
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial
MICHAEL SZAREK, Warren H. Capell, J. Ycas, MARIO ENRICO CANONICO et al.
Citations
1 citations
Journal
Circulation Cardiovascular Interventions
Topics
Peripheral Artery Disease Management
Field-Weighted Citation Impact (FWCI)
39.15
article
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial
MICHAEL SZAREK, Warren H. Capell, J. Ycas, MARIO ENRICO CANONICO, Connie Hess, Mark Nehler, Sonia Anand, Manesh Patel, Eva Muehlhofer, Rupert Bauersachs, Lloyd Haskell, Marc P. Bonaca, Scott D. Berkowitz, E. Sebastian Debus, Jessica Parr, Julian Chen, Mark Svet
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Circulation Cardiovascular Interventions
Institutions
University of Minnesota (US), Universität Hamburg (DE), SUNY Downstate Health Sciences University (US), Johannes Gutenberg University Mainz (DE), Population Health Research Institute (CA), Cardiovascular Center Bethanien (DE), University Medical Center Hamburg-Eppendorf (DE), Museum of the Rockies (US), Duke Medical Center (US), I.R.C.C.S. Oasi Maria SS (IT), Agaplesion Bethanien Krankenhaus (DE), Janssen (United States) (US), American Thrombosis and Hemostasis Network (US), Bayer (Germany) (DE), University of Colorado Denver (US)